Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 3, 2026

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

Sorting through new biomarkers.

Frances O Wood1, James A de Lemos

  • 1Cardiovascular Division and Department of Internal Medicine, UT Southwestern Medical Center, 5909 Harry Hines Boulevard, HA 9.108, Dallas, TX 75390-9047, USA.

Current Cardiology Reports
|July 10, 2008
PubMed
Summary

Early diagnosis of acute coronary syndromes (ACS) is crucial. New cardiac biomarkers beyond troponin can improve risk stratification and guide treatment decisions for better patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intensive Blood Pressure Lowering in Individuals With Low Diastolic Blood Pressure and Elevated Troponin Levels in SPRINT.

Journal of the American Heart Association·2024
Same author

Circulating transthyretin and retinol binding protein 4 levels among middle-age V122I <i>TTR</i> carriers in the general population.

Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis·2024
Same author

Convalescent Phenotyping of Cardiac Injury During Hospitalization for Acute COVID-19.

The American journal of cardiology·2024
Same author

Novel plasma biomarkers of coronary artery calcium incidence or progression: Insights from the prospective multi-ethnic Dallas Heart Study cohort.

Atherosclerosis·2024
Same author

National Variation in Hospital MTEER Outcomes and Correlation With TAVR Outcomes: STS/ACC TVT Registry Analysis.

JACC. Cardiovascular interventions·2024
Same author

Tirzepatide Reduces 24-Hour Ambulatory Blood Pressure in Adults With Body Mass Index ≥27 kg/m<sup>2</sup>: SURMOUNT-1 Ambulatory Blood Pressure Monitoring Substudy.

Hypertension (Dallas, Tex. : 1979)·2024

Area of Science:

  • Cardiology
  • Biomarker Discovery

Background:

  • Early diagnosis of acute coronary syndromes (ACS) is vital for risk stratification and timely treatment.
  • Current guidelines primarily recommend troponin testing for non-ST-elevation ACS.
  • There is a need for additional biomarkers to enhance ACS management.

Purpose of the Study:

  • To review emerging data on cardiac biomarkers for ACS.
  • To assess the utility of novel biomarkers in improving risk stratification and therapeutic decisions.
  • To highlight biomarkers that may aid in early diagnosis and monitoring of ACS.

Main Methods:

  • Review of current literature on cardiac biomarkers in ACS.
  • Assessment of data on troponins, B-type natriuretic peptides (BNPs), myeloperoxidase, fatty acid-binding protein, and monocyte chemoattractant protein-1.
  • Discussion of novel biomarkers such as growth-deficient factor-15 and neopterin.

Main Results:

  • Troponin remains a key biomarker, but others show promise.
  • B-type natriuretic peptides (BNPs) and C-reactive protein have supporting data for selected use.
  • Emerging biomarkers like myeloperoxidase, fatty acid-binding protein, monocyte chemoattractant protein-1, growth-deficient factor-15, and neopterin warrant further investigation.

Conclusions:

  • Additional cardiac biomarkers beyond troponin can enhance ACS diagnosis and risk stratification.
  • These biomarkers may help guide early invasive treatment decisions and monitor therapy response.
  • Further research into novel biomarkers is essential for optimizing cardiovascular medicine in ACS.

More Related Videos

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

Related Experiment Videos

Last Updated: Jul 3, 2026

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014